SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic

SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic

ObjectivesImpact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on individuals with arthritis has been highlighted whereas data on other rheumatic diseases, e.g., systemic lupus erythematosus (SLE), are scarce. Similarly to SLE, severe SARS-CoV-2 infection includes risk...

Full description

Bibliographic Details
Main Authors: Johanna Sjöwall, Mohammad Azharuddin, Martina Frodlund, Yuming Zhang, Laura Sandner, Charlotte Dahle, Jorma Hinkula, Christopher Sjöwall
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
COVID-19
lupus (SLE)
antibody response
neutralization (effect of)
antinuclear antibodies
complement-immunological terms
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.724047/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.724047/full

Similar Items